Tian Xu

发表

Mst1/Mst2 Regulate Development and Function of Regulatory T Cells through Modulation of Foxo1/Foxo3 Stability in Autoimmune Disease

Yongli Dong, W. Tao, Zengqiang Yuan, 2014, The Journal of Immunology.

Rhbdd3 controls autoimmunity by suppressing the production of IL-6 by dendritic cells via K27-linked ubiquitination of the regulator NEMO

Tian Xu, Y. Zhuang, Xuetao Cao, 2014, Nature Immunology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

HistoneMethyltransferaseAsh 1 lSuppresses Interleukin-6 Production and Inflammatory Autoimmune Diseases by Inducing the Ubiquitin-Editing Enzyme A 20

Tian Xu, Xuetao Cao, Jianli Wang, 2013 .

Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20.

Tian Xu, Xuetao Cao, Jianli Wang, 2013, Immunity.

ADAM10 is essential for proteolytic activation of Notch during thymocyte development.

Min Han, Tian Xu, Y. Zhuang, 2008, International immunology.

Rhomboid domain-containing protein 3 is a negative regulator of TLR3-triggered natural killer cell activation

Tian Xu, Xuetao Cao, M. Jiang, 2013, Proceedings of the National Academy of Sciences.

LINC00641/miR-582-5p mediate oxaliplatin resistance by activating autophagy in gastric adenocarcinoma

Tian Xu, Hong Zhao, Xiaozhi Zhang, 2020, Scientific Reports.

Berberine inhibits cancer cells growth by suppressing fatty acid synthesis and biogenesis of extracellular vesicles.

Xuhong Song, Dongyang Huang, B. Liang, 2020, Life sciences.

Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON

Amanda R. Campbell, B. Ramaswamy, Lianbo Yu, 2018, Cancer Immunology Research.

Aberrant activation of CYR61 enhancers in colorectal cancer development

Xuhong Song, Dongyang Huang, B. Liang, 2019, Journal of experimental & clinical cancer research : CR.

Identification and optimization of 3-bromo-N'-(4-hydroxybenzylidene)-4-methylbenzohydrazide derivatives as mTOR inhibitors that induce autophagic cell death and apoptosis in triple-negative breast cancer.

L. Ouyang, Guan Wang, Tian Xu, 2021, European journal of medicinal chemistry.

Aurora-A mediated phosphorylation of LDHB promotes glycolysis and tumor progression by relieving the substrate-inhibition effect

Tian Xu, P. Gao, Huafeng Zhang, 2019, Nature Communications.

Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors.

L. Ouyang, Tian Xu, De-juan Sun, 2020, European journal of medicinal chemistry.

CHIR99021 and rpIL6 promote porcine parthenogenetic embryo development and blastocyst quality.

Tian Xu, L. Huo, Yi-Liang Miao, 2020, Theriogenology.

LAM-003, a Novel Oral Heat Shock Protein 90 Inhibitor for Treatment of Acute Myeloid Leukemia, Including Wild-Type and FMS-like Tyrosine Kinase 3 (FLT3)-Mutant Disease

J. Rothberg, Tian Xu, S. Halene, 2019, Blood.

Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitors

R. Bjornson, O. Acevedo, R. Halaban, 2013, Pigment cell & melanoma research.

A Cell-Intrinsic Role for Mst1 in Regulating Thymocyte Egress1

Min Han, Yongli Dong, W. Tao, 2009, The Journal of Immunology.

Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma.

Paul Beckett, Jonathan Rothberg, J. Rothberg, 2017, Blood.

LAM-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AML.

J. Rothberg, M. Andreeff, Tian Xu, 2019, Blood advances.

VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2

Guoqiang Chen, Peng-Yuan Yang, Hao-Jie Lu, 2017, Nature Communications.

Identi fi cation of apilimod as a fi rst-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma

J. Rothberg, Tian Xu, Meiling Zheng, 2017 .